Business Context and Reporting Period
Company: HealthSouth Corporation (Note: Input metadata referenced "Encompass Health Corp," but the filing text identifies the registrant as HealthSouth Corporation).
Filing Type: Form 10-Q (Quarterly Report).
Reporting Period: Three and six months ended June 30, 1999.
Business Overview: The Company provides outpatient and rehabilitative healthcare services through inpatient and outpatient rehabilitation facilities, surgery centers, diagnostic centers, and medical centers. As of June 30, 1999, it operated nearly 2,000 locations across 50 states, the UK, and Australia.
Key Financial Metrics
| Metric | Six Months Ended June 30, 1999 | Six Months Ended June 30, 1998 |
|---|---|---|
| Revenues | $2,078,179,000 | $1,917,844,000 |
| Net Income | $223,912,000 | $234,734,000 |
| Diluted EPS | $0.52 | $0.54 |
| Operating Cash Flow | $358,507,000 | $237,501,000 |
| Working Capital | $1,133,769,000 | $945,927,000 (Dec 31, 1998) |
| Total Debt (Long-term + Current) | $2,898,981,000 | $2,830,926,000 (Dec 31, 1998) |
| Cash and Equivalents | $166,603,000 | $138,827,000 (Dec 31, 1998) |
Margins: Operating unit expenses were 62.3% of revenues for the six months ended June 30, 1999, compared to 61.5% in the prior year period. The effective tax rate was approximately 39.5% for the quarter ended June 30, 1999.
Material Changes vs. Prior Period
- Revenue Growth: Revenues increased 8.4% year-over-year for the six-month period, driven by a 3.9% increase in same-store revenues and $134.6 million in new store revenues.
- Profitability Decline: Despite revenue growth, Net Income decreased 4.6% to $223.9 million. This was primarily due to increased interest expense ($84.5 million vs. $57.6 million) and higher depreciation/amortization ($190.3 million vs. $158.0 million).
- Volume vs. Rate: Same-store patient volume increased significantly (outpatient visits +14.2%, inpatient days +9.1%), but revenue per unit of service decreased (e.g., revenue per outpatient visit down 2.5%).
- Acquisitions: The Company acquired the American Rehabilitation Services division of Mariner Post-Acute Network for approximately $54.5 million in net cash, adding ~160 outpatient centers.
- Accounts Receivable: Days sales outstanding increased from 81.8 days (Dec 31, 1998) to 94.5 days (June 30, 1999), attributed to payor processing delays.
Guidance, Outlook, and Risks
- Strategic Spin-off: The Board gave preliminary approval to explore a tax-free spin-off of inpatient operations into a separate public company.
- Capital Allocation: The Company anticipates spending $100M–$200M on facility maintenance/expansion and $300M–$500M on share repurchases over the next 12 months. A plan to repurchase up to 70 million shares was announced in February 1999.
- Legal Proceedings: The Company is defending against consolidated securities class action lawsuits alleging misrepresentations regarding financial condition and the impact of the Balanced Budget Act of 1997. The Company believes claims are without merit but cannot predict outcomes.
- Year 2000 Compliance: The Company estimates remediation costs between $35M and $40M. The primary risk identified is a material failure in third-party payors' systems, which could delay reimbursements.
- Reimbursement Risk: Significant exposure to changes in Medicare/Medicaid reimbursement rates and policies, which could adversely affect future results.
Investor Verification Checklist
- Payor Delays: Verify the trend in days sales outstanding (94.5 days) and the Company's ability to collect receivables given the cited delays by payors.
- Spin-off Feasibility: Monitor progress on the proposed tax-free spin-off of inpatient operations and its potential impact on valuation.
- Legal Exposure: Track developments in the consolidated securities litigation regarding the Balanced Budget Act of 1997.
- Interest Rate Sensitivity: Assess the impact of variable rate debt ($1.39 billion) on future earnings given the Company's sensitivity analysis indicating a $13.9 million pre-tax earnings loss per 1% rate increase.
- Year 2000 Costs: Confirm actual remediation costs against the $35M–$40M estimate and monitor for any reimbursement disruptions from third-party payors.